Growth Metrics

Castle Biosciences (CSTL) Change in Account Payables (2018 - 2026)

Castle Biosciences' Change in Account Payables history spans 8 years, with the latest figure at -$17000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables rose 97.02% to -$17000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.1 million, a 170.4% increase, with the full-year FY2025 number at $3.1 million, up 170.4% from a year prior.
  • Change in Account Payables hit -$17000.0 in Q4 2025 for Castle Biosciences, down from $1.4 million in the prior quarter.
  • Over the last five years, Change in Account Payables for CSTL hit a ceiling of $3.9 million in Q1 2023 and a floor of -$2.2 million in Q3 2024.
  • Historically, Change in Account Payables has averaged $240650.0 across 5 years, with a median of -$28500.0 in 2021.
  • Biggest five-year swings in Change in Account Payables: tumbled 1935.71% in 2021 and later surged 1983.42% in 2023.
  • Tracing CSTL's Change in Account Payables over 5 years: stood at -$855000.0 in 2021, then tumbled by 83.98% to -$1.6 million in 2022, then soared by 291.61% to $3.0 million in 2023, then tumbled by 118.91% to -$570000.0 in 2024, then surged by 97.02% to -$17000.0 in 2025.
  • Business Quant data shows Change in Account Payables for CSTL at -$17000.0 in Q4 2025, $1.4 million in Q3 2025, and $1.1 million in Q2 2025.